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Supplemental figure S1. Effects of chronic mild stress (MS) via rearing on 
wire net on the metabolic state of mice. (a) Body weight on the first day and 3 
weeks after rearing on a wire net. (b) Food intake in the dark and light phase 
in control (CNT) and MS mice. (c) The plasma levels of glucose, triglycerides 
(TG), free fatty acids (FFAs), cholesterol, acetoacetate (AcAc) and 
β-hydroxybutyrate (BHB). (d) Measurement of O2 consumption (VO2)(left 
panel), CO2 production (VCO2)(middle panel), and respiratory quotient (RQ) 
(right panel) in CNT and MS mice. All data are expressed as the means ± 
SEM (n = 6-7/group).  
  
  
Supplemental figure S2. Rearing on a wire net for 1 week disturbed sleep, 
but did not impair glucose tolerance. Hourly time course (left panels) and 
6-hour bins (right panels; ZT0-6 (L1), ZT6-12 (L2), ZT12-18 (D1) and ZT18-24 
(D2)) for wakefulness (a), non-rapid eye movement (NREM) sleep (b) and 
rapid eye movement (REM) sleep (c), and slow-wave activity (SWA) in NREM 
sleep (d) after rearing on a wire net for 1 week. Mean duration of bouts (e) 
and episode number (f) of NREM and REM sleep across 24 hours. An 
intraperitoneal glucose tolerance test (GTT)(g) and an insulin tolerance test 
(ITT)(h) were performed in control (CNT) and chronic mild stress (MS) mice. 
All data are expressed as the means ± SEM (n = 5/group). *p < 0.05, CNT 
versus MS mice. 
  
  
 
Supplemental figure S3. Sleep changes in mice injected with vehicle, 
histamine H1 receptor antagonist (H1RA), or benzodiazepine (BZD); a 
comparison between control (CNT) and chronic mild stress (MS) mice. 
Six-hour bins (ZT0-6 (L1), ZT6-12 (L2), ZT12-18 (D1) and ZT18-24 (D2)) for 
wakefulness (a), non-rapid eye movement (NREM) sleep (b) and rapid eye 
movement (REM) sleep (c), and slow-wave activity (SWA) in NREM sleep (d). 
Sleep data of vehicle-treated CNT mice (rich blue bars) are duplicated in 
H1RA/BZD data. All data are expressed as the means ± SEM (n = 6/group). 
*p < 0.05, * * p < 0.01, vs vehicle-treated CNT. #p < 0.05, ##p < 0.01, CNT vs 
MS in vehicle, H1RA and BZD treatment respectively. (Data in Figure 5 was 
re-arranged in this figure.)  
 
  
  
Supplemental figure S4. Two kinds of sleep-inducing agents did not affect 
the metabolic state of control (CNT) or chronic mild stress (MS) mice. Body 
weight (a) and food intake in the dark and light phase (b) in mice injected 
with vehicle, histamine H1 receptor antagonist (H1RA), or benzodiazepine 
(BZD). (c) The plasma levels of glucose, triglycerides (TG), free fatty acids 
(FFAs), and cholesterol in CNT and MS mice. All data are expressed as the 
means ± SEM (n = 5/group).  
  
  
Supplemental figure S5. Increased histamine (HA) levels in chronic mild 
stress (MS) mice. HA contents in each region of the brain (left panel) and HA 
release (measured in the lateral ventricle via microdialysis)(right panel) in 
control (CNT) and MS mice (a). Histidine decarboxylase (HDC) mRNA 
expression in the hypothalamus (b). Coronal section through mouse TMN 
region showing c-fos-positive histaminergic neurons (c). Immunoreactivity 
for HDC (red) and c-fos (green) are localized in the TMN of control, MS, and 
orexin B-injected (ORX, 1 nmol, i.c.v.) mice (left figures). The merged image 
shows c-fos-positive HDC-immunoreactive cell bodies (shown by arrows). 
Cell numbers of c-fos-positive HDC cells are expressed as a percentage of the 
total HDC-immunoreactive cell numbers (right panel). Scale bar, 100 μm. 
Blue bars indicate control mice, red bars indicate MS mice, and green bars 
indicate orexin B-injected mice. All data are expressed as the means ± SEM 
(n = 6-8/group). *p < 0.05, **p < 0.01, versus CNT; #p < 0.05, ##p < 0.01, 
versus MS.  
 Supplemental figure S6. Inhibition of mast cell degranulation ameliorated 
the impairment of glucose tolerance in chronic mild stress (MS) mice. An 
intraperitoneal glucose tolerance test (GTT)(a) and an insulin tolerance test 
(ITT)(b) were performed in control (CNT) and MS mice injected with vehicle 
(left panels) or cromolyn (30 μg, i.c.v.)(right panels), a mast cell 
degranulation blocker. Histamine (HA) contents in each region of the brain 
(left panel) and HA release (measured in the lateral ventricle via 
microdialysis)(right panel) in cromolyn-treated CNT and cromolyn-treated 
MS mice (c). All data are expressed as the means ± SEM (a, b: n = 4-6/group, 
c: n = 7/group). *p < 0.05, CNT versus MS mice. 
  
  
Supplemental figure S7. Inhibition of mast cell degranulation enhanced 
slow-wave activity (SWA) during non-rapid eye movement (NREM) sleep in 
chronic mild stress (MS) mice. Time course for 6-hour bins (ZT0-6, ZT6-12, 
ZT12-18 and ZT18-24) of wakefulness (a), NREM sleep (b), rapid eye 
movement (REM) sleep (c), and SWA in NREM sleep (e) in control (CNT) and 
MS mice injected with vehicle or cromolyn (30 μg, i.c.v.). Hourly time course 
for SWA during NREM sleep (d) and mean duration of bouts (f)/episode 
number (g) of NREM and REM sleep over 24 hours after drug injection. All 
data are expressed as the means ± SEM (n = 6-7/group). *p < 0.05, vehicle 
versus cromolyn. aap < 0.01, vehicle-treated CNT versus vehicle-treated MS. 
  
  
Supplemental figure S8. Schematic drawing illustrating our model of the 
effect of chronic mild stress on glucose and sleep homeostasis. Chronic mild 
stress via rearing on a wire net for 3 weeks disturbed sleep quantity and 
impaired glucose tolerance. This chronic mild stress also increased mast cells 
in the brain and adipose tissue. Inhibition of mast cell function ameliorated 
the impairment in both glucose tolerance and sleep. Mast cells may 
contribute to sleep disturbance-induced dysregulation of glucose 
homeostasis. 
 
 
